0001855763-23-000004.txt : 20230725 0001855763-23-000004.hdr.sgml : 20230725 20230725140926 ACCESSION NUMBER: 0001855763-23-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230725 FILED AS OF DATE: 20230725 DATE AS OF CHANGE: 20230725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McKechnie William Edward CENTRAL INDEX KEY: 0001658613 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39874 FILM NUMBER: 231108007 MAIL ADDRESS: STREET 1: 305 MARGARET AVENUE CITY: KITCHENER STATE: A6 ZIP: N2H 6S4 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 4 1 primary_doc.xml PRIMARY DOCUMENT X0508 4 2023-07-25 0 0001348362 Lexaria Bioscience Corp. LEXX 0001658613 McKechnie William Edward 235 WESTVALE DRIVE WATERLOO A6 N2T 1Y1 ONTARIO, CANADA 1 0 0 0 0 common shares 13191 D Stock Options 3 2021-04-26 2026-04-26 Common Shares 1500 1500 D Stock Options 3 2021-06-08 2026-06-08 Common Shares 5000 6500 D Stock Options 3 2021-09-01 2026-09-01 Common Shares 1900 8400 D Stock Options 3.39 2022-03-08 2027-03-08 Common Shares 3400 11800 D Stock Options 1.96 2022-10-12 2027-10-12 Common Shares 18200 30000 D Stock Options 0.87 2023-07-25 4 A 0 5000 0 A 2023-07-25 2028-07-25 Common Shares 5000 35000 D Repriced from $5.31 pursuant to shareholder approval received on May 9, 2023 Repriced from $7.08 pursuant to shareholder approval received May 9, 2023 Repriced from $6.23 pursuant to shareholder approval received May 9, 2023 /William McKechnie/ 2023-07-25